Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke-Reference-Cited by-同舟云学术

Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke

Published:2024-01-24 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Liao Jun¹²^ORCID,Li Yi¹,Fan Li²,Sun Yuhan²,Gu Zhengyan²,Xu Qing-Qiang³,Wang Yun¹,Xiong Liyan¹,Xiao Kai³^ORCID,Chen Zhe-sheng⁴^ORCID,Ma Zhiwei⁵,Zhang Chuan¹,Wang Tingfang¹,Lu Ying²

Affiliation:

1. Shanghai Engineering Research Center of Organ Repair, School of Medicine, Shanghai University, Shanghai, 200444, China

2. Department of Pharmaceutical Sciences, School of Pharmacy, Naval Medical University, Shanghai, 200433, China

3. Lab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, China

4. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York 11439, United States

5. School of Biomedical Engineering, ShanghaiTech University, Shanghai, 201210, China

Funder

Natural Science Foundation of Shanghai Municipality

Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c10982

Reference58 articles.

1. Prevention of stroke: a global perspective

2. Acute Ischemic Stroke

3. Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke

4. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke

5. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke